David O'Connor, MD
Vascular Surgery · Hackensack, NJNPI 1063736510
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $179,718 of the $271,662 with a category attached, or 66.2%. 39 manufacturers reported payments, led by Silk Road Medical, Inc. at 27.6% of the total. Among vascular surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 688 payments — averaging $394.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$75K
- Terumo Medical Corporation$27K
- Cardiovascular Systems Inc.$23K
- Philips North America LLC$19K
- Bard Peripheral Vascular, Inc.$16K
- Cagent Vascular Inc$15K
- plus $97K from 33 others
Across 287 payments — averaging $2274.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$174K
- Inari Medical, Inc.$120K
- Abbott$92K
- Silk Road Medical, Inc.$78K
- Bard Peripheral Vascular, Inc.$72K
- Bolton Medical Inc$49K
- plus $68K from 4 others
What the payments were for
- Consulting fees$179,71866%
- Speaking & faculty fees$41,65515%
- Travel & lodging$20,6208%
- Food & beverage$29,66911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$73,513
- ENHANCE Transcarotid Peripheral Access Kit$61,200
- ENROUTE Transcarotid Stent System$46,692
- ENROUTE 0.014 Guidewire$46,692
- ENROUTE Transcarotid Stent$26,820
- Navicross$19,001
- TR Band$16,901
- Peripheral Orbital Atherectomy System$16,746
- (9520) IGT Devices Undivided$15,825
- GlideWire$15,489
- Serrantor$15,134
- ENROUTE .014 Guidewire$14,508
- R2P MISAGO$14,426
- METACROSS OTW$14,301
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$12,819
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$10,500
- Neuroguard Direct$8,250
- Artis pheno$7,905
- Aventus$7,640
- Diamondback Peripheral$7,468
How this compares
$271,662 in reported general payments places this provider in the 95th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $26,681 |
| XareltoRivaroxaban | 18 | $15,473 |
| ClopidogrelClopidogrel Bisulfate | 92 | $1,304 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $144 | $15,47318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 182 vascular surgery providers in New Jersey.
Other vascular surgery in Hackensack
- Michael WildermanHackensack$383K
- Kristin CookHackensack$34K
- Jae Hee ChoHackensack$16K
- Roxana KlineHackensack$12K
- Peter KaganHackensack$10K
- Steven EliasEnglewood$509K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.